Guidance Molecule SEMA3A Restricts Tumor Growth by Differentially Regulating the Proliferation of Tumor-Associated

Majken Wallerius1, Tatjana Wallmann1, Margarita Bartish1

  • 1Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institute, Stockholm, Sweden.

Cancer Research
|May 20, 2016
PubMed

Insights

Tumor-associated macrophages (TAMs) drive cancer progression. This study reveals SEMA3A controls TAM proliferation, promoting anti-tumor immunity and potentially offering a new therapeutic target.

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Oncology

Background:

  • Tumor-associated macrophages (TAMs) are crucial in cancer progression, immune suppression, and poor prognosis.
  • Understanding TAM heterogeneity and function is vital for developing effective cancer therapies.

Purpose of the Study:

  • To define the role of the guidance molecule SEMA3A in controlling TAM proliferation.
  • To investigate the mechanism by which SEMA3A influences TAM phenotypes and anti-tumor immunity.

Main Methods:

  • Investigated SEMA3A's effect on M1 and M2 macrophage proliferation in vitro and in vivo.
  • Utilized immunohistochemistry to analyze SEMA3A levels in human breast cancer specimens.
  • Correlated SEMA3A expression with immune cell markers and malignancy indicators.

Main Results:

  • Tumor cell-derived SEMA3A differentially regulated TAM proliferation via its receptor neuropilin 1.
  • SEMA3A promoted M1 macrophage expansion while restricting M2 macrophage proliferation.
  • M1 macrophage expansion enhanced natural killer (NK) and CD8(+) T cell recruitment and activity, inhibiting tumor growth.
  • In human breast cancer, SEMA3A levels correlated with M1, CD8(+) T cell, and NK cell markers, and inversely with malignancy indicators.

Conclusions:

  • SEMA3A plays a critical role in controlling TAM phenotype and function.
  • The SEMA3A-neuropilin 1 axis modulates anti-tumor immunity by influencing TAM polarization.
  • SEMA3A represents a potential therapeutic target for enhancing anti-tumor immune responses in cancer.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.9K